BETHLEHEM, Pa.--(BUSINESS WIRE)--B. Braun Medical Inc., a global leader in innovative healthcare products and services, today announced the launch of the ONGUARD™ Contained Medication System with TEVADAPTOR™ components, manufactured by Teva Medical Ltd. The innovative drug admixture and delivery system provides a new level of hazard protection and passive needlestick prevention to the nurses and pharmacists at the frontline of chemotherapy preparation and administration.
